{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:41:32Z","timestamp":1761486092352},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.coph.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T07:32:23Z","timestamp":1510385543000},"page":"118-125","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Management of eosinophilic esophagitis and celiac disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Rok Seon","family":"Choung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Katzka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2017.10.007_bib0385","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cgh.2009.06.023","article-title":"Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota","volume":"7","author":"Prasad","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0390","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ajg.2015.8","article-title":"Trends and racial\/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012","volume":"110","author":"Choung","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2017.10.007_bib0395","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ajg.2013.71","article-title":"ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)","volume":"108","author":"Dellon","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2017.10.007_bib0400","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2017.10.007_bib0405","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cgh.2012.03.018","article-title":"Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis","volume":"10","author":"Alexander","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0410","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MPG.0000000000000870","article-title":"ESPGHAN 2012 Guidelines for Coeliac Disease Diagnosis: validation through a retrospective Spanish Multicentric Study","volume":"62","author":"Donat","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2017.10.007_bib0415","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","article-title":"Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner","volume":"145","author":"Schoepfer","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0420","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2011.09.026","article-title":"Tissue remodeling in patients with eosinophilic esophagitis: what lies beneath the surface?","volume":"128","author":"Aceves","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2017.10.007_bib0425","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1542-3565(04)00236-8","article-title":"Eosinophilic esophagitis: asthma of the esophagus?","volume":"2","author":"Arora","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0430","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-3101(22)00464-9","article-title":"Celiac disease","volume":"9","author":"Dicke","year":"1957","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.coph.2017.10.007_sbref0435","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cgh.2016.11.032","article-title":"Cost utility analysis of topical steroids compared with dietary elimination for treatment of eosinophilic esophagitis","volume":"15","author":"Cotton","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0440","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","article-title":"Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis","volume":"146","author":"Arias","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0445","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaci.2014.07.023","article-title":"Four-food group elimination diet for adult eosinophilic esophagitis: a prospective multicenter study","volume":"134","author":"Molina-Infante","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2017.10.007_bib0450","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.2003.07390.x","article-title":"Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents","volume":"98","author":"Markowitz","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2017.10.007_bib0455","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ajg.2012.468","article-title":"Elemental diet induces histologic response in adult eosinophilic esophagitis","volume":"108","author":"Peterson","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2017.10.007_bib0460","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/apt.13953","article-title":"Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients","volume":"45","author":"Warners","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2017.10.007_bib0465","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2036.2008.03669.x","article-title":"Systematic review: tolerable amount of gluten for people with coeliac disease","volume":"27","author":"Akobeng","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2017.10.007_bib0470","unstructured":"Gluten-free labeling of food. 21CFR 101.91. 2016."},{"key":"10.1016\/j.coph.2017.10.007_bib0475","series-title":"Vital and health statistics. Series 2, Data evaluation and methods research","first-page":"1","article-title":"National health and nutrition examination survey: sample design, 2011\u20132014","author":"Johnson","year":"2014"},{"key":"10.1016\/j.coph.2017.10.007_bib0480","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ejcn.2014.211","article-title":"A comparison of gluten levels in labeled gluten-free and certified gluten-free foods sold in the United States","volume":"69","author":"Thompson","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.coph.2017.10.007_sbref0485","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.4315\/0362-028X.JFP-14-149","article-title":"Gluten contamination in foods labeled as \u2018gluten free\u2019 in the United States","volume":"77","author":"Lee","year":"2014","journal-title":"J Food Prot"},{"key":"10.1016\/j.coph.2017.10.007_bib0490","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1080\/19440049.2013.840744","article-title":"Gluten contamination of naturally gluten-free flours and starches used by Canadians with celiac disease","volume":"30","author":"Koerner","year":"2013","journal-title":"Food Addit Contam Part A: Chem Anal Control Expo Risk Assess"},{"key":"10.1016\/j.coph.2017.10.007_sbref0495","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1365-2036.2009.03983.x","article-title":"Patient perceptions of the burden of coeliac disease and its treatment in the UK","volume":"29","author":"Whitaker","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2017.10.007_bib0500","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-277X.2012.01288.x","article-title":"Living with coeliac disease and a gluten-free diet: a Canadian perspective","volume":"26","author":"Zarkadas","year":"2013","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.coph.2017.10.007_bib0505","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cgh.2007.11.008","article-title":"Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children","volume":"6","author":"Schaefer","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0510","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1053\/gast.2002.32998","article-title":"Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate","volume":"122","author":"Teitelbaum","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0515","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4065\/78.7.830","article-title":"Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults","volume":"78","author":"Arora","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.coph.2017.10.007_bib0520","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2006.08.033","article-title":"A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis","volume":"131","author":"Konikoff","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0525","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1542-3565(04)00240-X","article-title":"Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis","volume":"2","author":"Noel","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gie.2005.07.049","article-title":"Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate","volume":"63","author":"Remedios","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.coph.2017.10.007_bib0535","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10620-009-0859-4","article-title":"Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis","volume":"55","author":"Peterson","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2017.10.007_bib0540","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2010.05.001","article-title":"Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial","volume":"139","author":"Dohil","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0545","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2010.07.048","article-title":"Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis","volume":"139","author":"Straumann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0550","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jaci.2012.03.007","article-title":"Successful treatment of eosinophilic esophagitis with ciclesonide","volume":"129","author":"Schroeder","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2017.10.007_bib0555","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s10620-016-4110-9","article-title":"Comparisons of fluticasone to budesonide in the treatment of eosinophilic esophagitis","volume":"61","author":"Albert","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2017.10.007_sbref0560","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/gutjnl-2014-308815","article-title":"A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis","volume":"65","author":"Miehlke","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.coph.2017.10.007_sbref0565","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.gastro.2016.11.021","article-title":"Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis","volume":"152","author":"Dellon","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0570","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.gastro.2012.04.049","article-title":"Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis","volume":"143","author":"Dellon","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0575","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cgh.2011.01.017","article-title":"Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis","volume":"9","author":"Straumann","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0580","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cgh.2010.09.019","article-title":"Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults","volume":"9","author":"Molina-Infante","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0585","doi-asserted-by":"crossref","first-page":"e50037","DOI":"10.1371\/journal.pone.0050037","article-title":"Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2017.10.007_bib0590","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","article-title":"Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD","volume":"62","author":"Cheng","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.coph.2017.10.007_bib0595","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/gut.52.2.181","article-title":"Eosinophilic oesophagitis: a novel treatment using Montelukast","volume":"52","author":"Attwood","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.coph.2017.10.007_bib0600","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1007\/s10620-011-1775-y","article-title":"Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis","volume":"56","author":"Lucendo","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2017.10.007_sbref0605","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cgh.2016.09.013","article-title":"Montelukast does not maintain symptom remission after topical steroid therapy for eosinophilic esophagitis","volume":"15","author":"Alexander","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0610","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1067\/mai.2001.119917","article-title":"Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response","volume":"108","author":"Straumann","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2017.10.007_bib0615","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.mpg.0000188740.38757.d2","article-title":"Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis","volume":"42","author":"Gupta","year":"2006","journal-title":"J Ped Gastroenterol Nutr"},{"issue":"Suppl. 1","key":"10.1016\/j.coph.2017.10.007_bib0620","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1038\/sj.bjp.0707488","article-title":"The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses","volume":"153","author":"Pettipher","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2017.10.007_bib0625","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/all.12096","article-title":"Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis","volume":"68","author":"Straumann","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2017.10.007_bib0630","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2017.10.007_bib0635","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.coph.2017.10.007_bib0640","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa\u2019ad","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0645","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2017.10.007_bib0650","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaci.2008.06.012","article-title":"Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis","volume":"122","author":"Straumann","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2017.10.007_bib0655","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1038\/ajg.2016.356","article-title":"A randomized, double-blind, placebo-controlled trial of a novel recombinant, humanized, anti-interleukin-13 monoclonal antibody (RPC4046) in patients with active eosinophilic esophagitis: results of the HEROES study","volume":"111","author":"Dellon","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2017.10.007_bib0660","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/MEG.0b013e32825a6ab4","article-title":"Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission","volume":"19","author":"Netzer","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0665","doi-asserted-by":"crossref","first-page":"G996-G1003","DOI":"10.1152\/ajpgi.00136.2002","article-title":"Intestinal digestive resistance of immunodominant gliadin peptides","volume":"283","author":"Hausch","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2017.10.007_bib0670","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1124\/jpet.104.068429","article-title":"Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo","volume":"311","author":"Piper","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2017.10.007_sbref0675","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0680","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"Lahdeaho","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0685","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/S0016-5085(17)30865-X","article-title":"Oral Latiglutenase improves chronic symptoms in seropositive celiac disease patients","volume":"152","author":"Syage","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0690","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2011.10.038","article-title":"The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues","volume":"142","author":"Pinier","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_bib0695","doi-asserted-by":"crossref","first-page":"e109972","DOI":"10.1371\/journal.pone.0109972","article-title":"BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity","volume":"9","author":"McCarville","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2017.10.007_bib0700","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI119271","article-title":"Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model","volume":"99","author":"Fasano","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2017.10.007_bib0705","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2007.03413.x","article-title":"The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study","volume":"26","author":"Paterson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2017.10.007_bib0710","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.12147","article-title":"Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study","volume":"37","author":"Kelly","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2017.10.007_bib0715","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/ajg.2012.211","article-title":"A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge","volume":"107","author":"Leffler","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2017.10.007_bib0720","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2017.10.007_sbref0725","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.10.007_bib0730","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.it.2015.05.007","article-title":"Harnessing nanoparticles for immune modulation","volume":"36","author":"Getts","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coph.2017.10.007_bib0735","doi-asserted-by":"crossref","first-page":"e30642","DOI":"10.1371\/journal.pone.0030642","article-title":"Activation and inhibition of transglutaminase 2 in mice","volume":"7","author":"Dafik","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2017.10.007_bib0740","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2796.2011.02376.x","article-title":"Novel therapies for coeliac disease","volume":"269","author":"Sollid","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.coph.2017.10.007_bib0745","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","article-title":"Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease","volume":"55","author":"Di Sabatino","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.coph.2017.10.007_bib0750","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","article-title":"IL-15: a central regulator of celiac disease immunopathology","volume":"260","author":"Abadie","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coph.2017.10.007_sbref0755","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ajg.2017.71","article-title":"Open-capsule budesonide for refractory celiac disease","volume":"112","author":"Mukewar","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2017.10.007_bib0760","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217300656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217300656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T10:51:22Z","timestamp":1693219882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489217300656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":76,"alternative-id":["S1471489217300656"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2017.10.007","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of eosinophilic esophagitis and celiac disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}